Synovis Life Technologies

Synovis Life Technologies was a Minneapolis-based medical-device company focused on the development and manufacture of products used in medical and surgical applications. The company operated under the name Bio-Vascular, Inc. until May 1, 2002, when it adopted the Synovis Life Technologies name to signal a broader product portfolio rather than a business centered on a single vascular specialty. The company’s public profile grew during the 2000s. It was included in the 2004 Fortune 100 Fastest Growing Companies ranking and also appeared on Forbes lists of the 200 Best Small Companies. Synovis was included in the Russell 2000 Index, reflecting its status as a publicly traded smaller-capitalization company during this period. These recognitions indicate that the business had achieved meaningful growth and scale, although detailed financial information is not included here without a directly cited annual-report source. According to the company’s 2010 annual-report information summarized in the Wikipedia article, Synovis had been publicly traded since 1985. At that time, Richard W. Kramp was identified as president and chief executive officer, while John D. Seaberg served as chairman of the board. The company’s activities were described broadly as the manufacture of medical devices, with the rebranding from Bio-Vascular intended to reflect diversification across product categories. Synovis remained an independent public company until February 2012, when Baxter International acquired it. The transaction ended Synovis’s existence as a standalone publicly traded company and brought its medical-device activities into Baxter’s larger healthcare portfolio. Because the available reference material does not specify which product lines continued under the Synovis name after the acquisition, the brand’s post-acquisition operating status and current commercial use are not separately identified here.

Synovis Life Technologies was a United States medical-device manufacturer headquartered in Minneapolis, Minnesota. The company’s earlier corporate name was Bio-Vascular, Inc., a designation that reflected a more focused vascular orientation. On May 1, 2002, it changed its name to Synovis Life Technologies. The new name was intended to represent a broader range of products and technologies as the company diversified its business. The company’s growth became visible through a series of business and market recognitions during the 2000s. Synovis was included in Fortune’s 2004 ranking of the 100 fastest-growing companies. It also appeared on Forbes lists recognizing the 200 Best Small Companies and was included in the Russell 2000 Index. These references place Synovis among the smaller publicly traded United States companies that attracted attention for growth and operating performance during that period. Synovis had been publicly traded since 1985, according to information attributed to its 2010 annual report. The same material identified Richard W. Kramp as president and chief executive officer and John D. Seaberg as chairman of the board. The company was described as manufacturing various medical devices, but the available reference does not provide a sufficiently detailed product catalog to identify individual commercial product families with confidence. The 2002 renaming was an important strategic and corporate-identity milestone. It moved the company away from a name associated primarily with vascular products and toward a life-technologies formulation capable of covering a more diversified medical-device portfolio. This positioning was consistent with the company’s subsequent description as a manufacturer of a range of medical devices rather than a single-purpose vascular specialist. In February 2012, Baxter International acquired Synovis Life Technologies. The acquisition brought Synovis into Baxter’s healthcare business and concluded the company’s period as an independent public corporation. Following the transaction, the available reference material does not establish whether all Synovis products continued under the Synovis name, were integrated into Baxter operations, or were marketed under other identities. For that reason, the entry treats Synovis as a defunct standalone company while avoiding unsupported claims about the current status of any individual product or trademark.

• 2012

  Acquired by Baxter International

  [1]Synovis Life Technologiesen.wikipedia.org

  Baxter International acquired Synovis in February, ending the company’s independent corporate existence.

• 2004

  Included in Fortune’s fastest-growing companies ranking

  [1]Synovis Life Technologiesen.wikipedia.org

  Synovis appeared in Fortune’s 100 Fastest Growing Companies list.

• 2002

  Corporate name changed to Synovis Life Technologies

  [1]Synovis Life Technologiesen.wikipedia.org

  On May 1, the company replaced the Bio-Vascular, Inc. name to reflect a more diversified medical-device business.

• 1985

  Public listing

  [1]Synovis Life Technologiesen.wikipedia.org

  The company’s 2010 annual-report information stated that it had gone public in 1985.

A growth-oriented specialty medical-device manufacturer that expanded from a vascular-focused identity into a broader life-technologies portfolio.

• Medical devices

  Medical devices

  Synovis manufactured a range of medical devices for healthcare and surgical applications. The available reference describes the portfolio only at a general level and does not identify enough specific products to construct a reliable line-by-line catalog.

• 2012

  Accepted acquisition by Baxter InternationalM&A

  Background

  Synovis was an established specialty medical-device company with a history as a publicly traded business.

  Action taken

  Baxter International acquired Synovis Life Technologies in February 2012.

  Aftermath

  Synovis ceased operating as an independent public company and became part of Baxter International.

  Source

• 2002

  Adopted a broader corporate identityStrategy

  Background

  The Bio-Vascular name no longer fully represented the company’s expanding range of medical-device activities.

  Action taken

  The company changed its name to Synovis Life Technologies on May 1, 2002.

  Aftermath

  The new identity positioned the company as a diversified life-technologies and medical-device manufacturer.

  Source

1. 1Synovis Life Technologiesen.wikipedia.org